META vs MRK: Which Is the Better Buy?
Side-by-side comparison of Meta Platforms, Inc. and Merck & Co., Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-20.
Meta Platforms, Inc. · Communication Services
$671.34
+36.4% upside to fair value
Grade B
High Quality
VS
Merck & Co., Inc. · Healthcare
$114.27
+3.3% upside to fair value
Grade C
High Quality
QuantHub Verdict
META has more upside to fair value
(+36.4%).
MRK trades at a lower forward P/E
(22.4x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
META |
MRK |
| Current Price |
$671.34 |
$114.27 |
| Fair Value Estimate |
$916.00 |
$118.00 |
| Upside to Fair Value |
+36.4%
|
+3.3%
|
| Market Cap |
$1,698.2B |
$282.2B |
| Forward P/E |
28.0x
|
22.4x
|
| EV / EBITDA |
16.5x
|
13.5x
|
| Price / Sales |
8.4x
|
4.3x
|
| Price / FCF |
36.8x
|
20.2x
|
| Revenue Growth YoY |
+23.8%
|
+5.0%
|
| Gross Margin |
82.0%
|
81.9%
|
| Operating Margin |
41.4%
|
27.5%
|
| Return on Equity |
30.6%
|
5.6%
|
| Dividend Yield |
0% |
2.91% |
| FCF Yield |
2.72%
|
4.95%
|
| Analyst Consensus |
Strong Buy
|
Overweight
|
Investment Thesis
Meta Platforms, Inc. operates a leading global social media and technology platform primarily through its Family of Apps segment, which generates over 98% of its $201 billion 2025 revenue, driven by strong advertising growth. The company maintains a high-quality business with a durable competitive moat supported by network effects, brand strength, and intangible assets, reflected in a 30.6% retur…
Merck delivered a clean Q1 2026 operational beat on April 30, with revenue of 16.3 billion dollars growing 5 percent year over year and Keytruda sales rising 12 percent to 8.0 billion dollars. The reported loss of 1.28 dollars per share, though better than the negative 1.47 dollar consensus estimate, reflected a 3.62 dollar per share IPR and D charge tied to the Cidara Therapeutics acquisition an…
Accumulation Zones
| Metric |
META |
MRK |
| Zone Low |
$687.00 |
$88.50 |
| Zone High |
$778.60 |
$100.30 |
| In Buy Zone? |
Yes
|
No
|